One hundred and forty-one attempts at percutaneous transhepatic variceal obliteration were made in 116 @entity1 with portal @entity101 complicated by @entity548 . Varices were successfully obliterated in 80% of procedures and included 37 @entity1 with continuous, @entity548 . @entity548 ceased immediately in these @entity1 . Sixty-five percent of @entity1 rebled a mean of 4.6 mo after successful transhepatic variceal obliteration. A randomized controlled trial against conventional medical therapy (29 treatment, 25 control) failed to show a significant reduction in death rate after transhepatic sclerotherapy, although the onset of further @entity548 was delayed. Follow-up portography in 50 @entity1 demonstrated new vessel formation in 38 @entity1 and recanalization of previously occluded varices in 5 @entity1 . Complications arose in 29 of 141 procedures. There was one death but all the other complications responded to conservative management. Transhepatic variceal obliteration is an excellent, safe emergency treatment for @entity548 , especially in @entity1 with decompensated @entity409 . A high incidence of rebleeding is a long-term disadvantage and means that transhepatic variceal obliteration should not be used for the prophylaxis of @entity548 . Successful emergency treatment of @entity548 should be followed by elective portal decompression in suitable @entity1 .

Role of percutaneous transhepatic obliteration of varices in the management of XXXX from gastroesophageal varices.

@entity1 :: ('9606', 'Species') :: ['patients'] @entity409 :: ('MESH:D008107', 'Disease') :: ['liver disease'] @entity101 :: ('MESH:D006973', 'Disease') :: ['hypertension'] @entity548 :: ('MESH:D006470', 'Disease') :: ['variceal hemorrhage', 'Hemorrhage', 'acute variceal hemorrhage']
@entity548 :: (MESH:D006470,Disease) :: ['hemorrhage']
